{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:19Z","timestamp":1790776339793,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-ASTR-0021"],"award-info":[{"award-number":["ANR-22-ASTR-0021"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The hypoxia response pathway enables adaptation to oxygen deprivation. It is mediated by hypoxia-inducible factors (HIF), which promote metabolic reprogramming, erythropoiesis, angiogenesis and tissue remodeling. This led to the successful development of HIF-inducing drugs for treating anemia and some of these molecules are now in clinic. However, elevated levels of HIFs are frequently associated with tumor growth, poor prognosis, and drug resistance in various cancers, including hepatocellular carcinoma (HCC). Consequently, there are concerns regarding the recommendation of HIF-inducing drugs in certain clinical situations. Here, we analyzed the effects of two HIF-inducing drugs, Molidustat and Roxadustat, in the well-characterized HCC cell line Huh7. These drugs increased HIF-1\u03b1 and HIF-2\u03b1 protein levels which both participate in inducing hypoxia response genes such as BNIP3, SERPINE1, LDHA or EPO. Combined transcriptomics, proteomics and metabolomics showed that Molidustat increased the expression of glycolytic enzymes, while the mitochondrial network was fragmented and cellular respiration decreased. This metabolic remodeling was associated with a reduced proliferation and a lower demand for pyrimidine supply, but an increased ability of cells to convert pyruvate to lactate. This was accompanied by a higher resistance to the inhibition of mitochondrial respiration by antimycin A, a phenotype confirmed in Roxadustat-treated Huh7 cells and Molidustat-treated hepatoblastoma cells (Huh6 and HepG2). Overall, this study shows that HIF-inducing drugs increase the metabolic resilience of liver cancer cells to metabolic stressors, arguing for careful monitoring of patients treated with HIF-inducing drugs, especially when they are at risk of liver cancer.<\/jats:p>","DOI":"10.1007\/s00018-024-05361-6","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:02:15Z","timestamp":1722333735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological induction of the hypoxia response pathway in Huh7 hepatoma cells limits proliferation but increases resilience under metabolic stress"],"prefix":"10.1007","volume":"81","author":[{"given":"Cl\u00e9mence","family":"Jacquemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"El Orch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3451-9914","authenticated-orcid":false,"given":"Olivier","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Lalande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Aublin-Gex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentine","family":"Jacolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Toesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-7742","authenticated-orcid":false,"given":"Mustapha","family":"Si-Tahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-2029","authenticated-orcid":false,"given":"Cyrille","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-3282","authenticated-orcid":false,"given":"Vincent","family":"Lotteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-6733","authenticated-orcid":false,"given":"Laure","family":"Perrin-Cocon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3082-7407","authenticated-orcid":false,"given":"Pierre-Olivier","family":"Vidalain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"5361_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cmet.2018.10.014","volume":"29","author":"M Bajzikova","year":"2019","unstructured":"Bajzikova M, Kovarova J, Coelho AR et al (2019) Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells. Cell Metab 29:399-416.e10. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.014","journal-title":"Cell Metab"},{"key":"5361_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41586-020-2475-6","volume":"585","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Cardona LR, Kong H et al (2020) Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature 585:288\u2013292. https:\/\/doi.org\/10.1038\/s41586-020-2475-6","journal-title":"Nature"},{"key":"5361_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy K, Wang T, Chen WW et al (2015) An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162:540\u2013551. https:\/\/doi.org\/10.1016\/j.cell.2015.07.016","journal-title":"Cell"},{"key":"5361_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","volume":"162","author":"LB Sullivan","year":"2015","unstructured":"Sullivan LB, Gui DY, Hosios AM et al (2015) Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162:552\u2013563. https:\/\/doi.org\/10.1016\/j.cell.2015.07.017","journal-title":"Cell"},{"key":"5361_CR5","doi-asserted-by":"publisher","first-page":"e 112067","DOI":"10.15252\/embj.2022112067","volume":"42","author":"R Missiaen","year":"2023","unstructured":"Missiaen R, Lesner NP, Simon MC (2023) HIF: a master regulator of nutrient availability and metabolic cross-talk in the tumor microenvironment. EMBO J 42:e 112067. https:\/\/doi.org\/10.15252\/embj.2022112067","journal-title":"EMBO J"},{"key":"5361_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J et al (2013) Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496:238\u2013242. https:\/\/doi.org\/10.1038\/nature11986","journal-title":"Nature"},{"key":"5361_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.4049\/jimmunol.1701522","volume":"201","author":"L Perrin-Cocon","year":"2018","unstructured":"Perrin-Cocon L, Aublin-Gex A, Diaz O et al (2018) Toll-like receptor 4-induced glycolytic burst in human monocyte-derived dendritic cells results from p38-dependent stabilization of HIF-1\u03b1 and increased hexokinase II expression. J Immunol 201:1510\u20131521. https:\/\/doi.org\/10.4049\/jimmunol.1701522","journal-title":"J Immunol"},{"key":"5361_CR8","doi-asserted-by":"publisher","first-page":"8162","DOI":"10.3390\/ijms21218162","volume":"21","author":"G Yang","year":"2020","unstructured":"Yang G, Shi R, Zhang Q (2020) Hypoxia and oxygen-sensing signaling in gene regulation and cancer progression. Int J Mol Sci 21:8162. https:\/\/doi.org\/10.3390\/ijms21218162","journal-title":"Int J Mol Sci"},{"key":"5361_CR9","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","volume":"61","author":"AA Joharapurkar","year":"2018","unstructured":"Joharapurkar AA, Pandya VB, Patel VJ et al (2018) Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases. J Med Chem 61:6964\u20136982. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01686","journal-title":"J Med Chem"},{"key":"5361_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/HP.S47598","volume":"2","author":"T Bishop","year":"2014","unstructured":"Bishop T, Ratcliffe PJ (2014) Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives. Hypoxia (Auckl) 2:197\u2013213. https:\/\/doi.org\/10.2147\/HP.S47598","journal-title":"Hypoxia (Auckl)"},{"key":"5361_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/cells10071715","volume":"10","author":"MH-R Bao","year":"2021","unstructured":"Bao MH-R, Wong CC-L (2021) Hypoxia, metabolic reprogramming, and drug resistance in liver cancer. Cells 10:1715. https:\/\/doi.org\/10.3390\/cells10071715","journal-title":"Cells"},{"key":"5361_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159839","volume":"132","author":"EE Wicks","year":"2022","unstructured":"Wicks EE, Semenza GL (2022) Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest 132:e159839. https:\/\/doi.org\/10.1172\/JCI159839","journal-title":"J Clin Invest"},{"key":"5361_CR13","doi-asserted-by":"publisher","first-page":"C775","DOI":"10.1152\/ajpcell.00279.2015","volume":"309","author":"ME Hubbi","year":"2015","unstructured":"Hubbi ME, Semenza GL (2015) Regulation of cell proliferation by hypoxia-inducible factors. Am J Physiol Cell Physiol 309:C775-782. https:\/\/doi.org\/10.1152\/ajpcell.00279.2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"5361_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/onc.2009.441","volume":"29","author":"GL Semenza","year":"2010","unstructured":"Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625\u2013634. https:\/\/doi.org\/10.1038\/onc.2009.441","journal-title":"Oncogene"},{"key":"5361_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156774","volume":"132","author":"S Salman","year":"2022","unstructured":"Salman S, Meyers DJ, Wicks EE et al (2022) HIF inhibitor 32\u2013134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy. J Clin Invest 132:e156774. https:\/\/doi.org\/10.1172\/JCI156774","journal-title":"J Clin Invest"},{"key":"5361_CR16","doi-asserted-by":"publisher","first-page":"1170796","DOI":"10.3389\/fphar.2023.1170796","volume":"14","author":"H Waldum","year":"2023","unstructured":"Waldum H (2023) Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer. Front Pharmacol 14:1170796. https:\/\/doi.org\/10.3389\/fphar.2023.1170796","journal-title":"Front Pharmacol"},{"key":"5361_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/HP.S130526","volume":"5","author":"TW Seeley","year":"2017","unstructured":"Seeley TW, Sternlicht MD, Klaus SJ et al (2017) Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. Hypoxia (Auckl) 5:1\u20139. https:\/\/doi.org\/10.2147\/HP.S130526","journal-title":"Hypoxia (Auckl)"},{"key":"5361_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1177\/1091581817737232","volume":"36","author":"J Beck","year":"2017","unstructured":"Beck J, Henschel C, Chou J et al (2017) Evaluation of the carcinogenic potential of roxadustat (FG-4592), a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase in CD-1 mice and sprague dawley rats. Int J Toxicol 36:427\u2013439. https:\/\/doi.org\/10.1177\/1091581817737232","journal-title":"Int J Toxicol"},{"key":"5361_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/0192623319880445","volume":"48","author":"DF Adams","year":"2020","unstructured":"Adams DF, Watkins MS, Durette L et al (2020) Carcinogenicity assessment of daprodustat (GSK1278863), a hypoxia-inducible factor (HIF)-prolyl hydroxylase inhibitor. Toxicol Pathol 48:362\u2013378. https:\/\/doi.org\/10.1177\/0192623319880445","journal-title":"Toxicol Pathol"},{"key":"5361_CR20","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/ndt\/gfac342","volume":"38","author":"AK Singh","year":"2023","unstructured":"Singh AK, McCausland FR, Claggett BL et al (2023) Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials. Nephrol Dial Transplant 38:1890\u20131897. https:\/\/doi.org\/10.1093\/ndt\/gfac342","journal-title":"Nephrol Dial Transplant"},{"key":"5361_CR21","doi-asserted-by":"publisher","first-page":"2195011","DOI":"10.1080\/0886022X.2023.2195011","volume":"45","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Mao M, Li J, Deng F (2023) The efficacy and safety of roxadustat for anemia in patients with dialysis-dependent chronic kidney disease: a systematic review and meta-analysis. Ren Fail 45:2195011. https:\/\/doi.org\/10.1080\/0886022X.2023.2195011","journal-title":"Ren Fail"},{"key":"5361_CR22","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.isci.2019.08.033","volume":"19","author":"S Nishide","year":"2019","unstructured":"Nishide S, Matsunaga S, Shiota M et al (2019) Controlling the phenotype of tumor-infiltrating macrophages via the PHD-HIF axis inhibits tumor growth in a mouse model. iScience 19:940\u2013954. https:\/\/doi.org\/10.1016\/j.isci.2019.08.033","journal-title":"iScience"},{"key":"5361_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113922","volume":"175","author":"N Kachamakova-Trojanowska","year":"2020","unstructured":"Kachamakova-Trojanowska N, Podkalicka P, Bogacz T et al (2020) HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo. Biochem Pharmacol 175:113922. https:\/\/doi.org\/10.1016\/j.bcp.2020.113922","journal-title":"Biochem Pharmacol"},{"key":"5361_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41419-022-05304-8","volume":"13","author":"X Su","year":"2022","unstructured":"Su X, Xie Y, Zhang J et al (2022) HIF-\u03b1 activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death Dis 13:861. https:\/\/doi.org\/10.1038\/s41419-022-05304-8","journal-title":"Cell Death Dis"},{"key":"5361_CR25","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380:1450\u20131462. https:\/\/doi.org\/10.1056\/NEJMra1713263","journal-title":"N Engl J Med"},{"key":"5361_CR26","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.3390\/cancers15102738","volume":"15","author":"KN Huynh","year":"2023","unstructured":"Huynh KN, Rao S, Roth B et al (2023) Targeting hypoxia-inducible factor-1\u03b1 for the management of hepatocellular carcinoma. Cancers (Basel) 15:2738. https:\/\/doi.org\/10.3390\/cancers15102738","journal-title":"Cancers (Basel)"},{"key":"5361_CR27","doi-asserted-by":"publisher","first-page":"9651","DOI":"10.1074\/jbc.M111.299180","volume":"287","author":"A Romero-Ruiz","year":"2012","unstructured":"Romero-Ruiz A, Bautista L, Navarro V et al (2012) Prolyl hydroxylase-dependent modulation of eukaryotic elongation factor 2 activity and protein translation under acute hypoxia. J Biol Chem 287:9651\u20139658. https:\/\/doi.org\/10.1074\/jbc.M111.299180","journal-title":"J Biol Chem"},{"key":"5361_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s42003-021-01749-3","volume":"4","author":"L Perrin-Cocon","year":"2021","unstructured":"Perrin-Cocon L, Vidalain P-O, Jacquemin C et al (2021) A hexokinase isoenzyme switch in human liver cancer cells promotes lipogenesis and enhances innate immunity. Commun Biol 4:217. https:\/\/doi.org\/10.1038\/s42003-021-01749-3","journal-title":"Commun Biol"},{"key":"5361_CR29","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1038\/s41388-021-01848-9","volume":"40","author":"M Shen","year":"2021","unstructured":"Shen M, Zhang R, Jia W et al (2021) Nuclear scaffold protein p54nrb\/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma. Oncogene 40:4167\u20134183. https:\/\/doi.org\/10.1038\/s41388-021-01848-9","journal-title":"Oncogene"},{"key":"5361_CR30","doi-asserted-by":"publisher","first-page":"14101","DOI":"10.1038\/s41598-020-70865-7","volume":"10","author":"PJ Liu","year":"2020","unstructured":"Liu PJ, Harris JM, Marchi E et al (2020) Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models. Sci Rep 10:14101. https:\/\/doi.org\/10.1038\/s41598-020-70865-7","journal-title":"Sci Rep"},{"issue":"Suppl 2","key":"5361_CR31","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1755-8794-8-S2-S5","volume":"8","author":"B Chen","year":"2015","unstructured":"Chen B, Sirota M, Fan-Minogue H et al (2015) Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research. BMC Med Genom 8(Suppl 2):S5. https:\/\/doi.org\/10.1186\/1755-8794-8-S2-S5","journal-title":"BMC Med Genom"},{"key":"5361_CR32","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/cmdc.201700783","volume":"13","author":"H Beck","year":"2018","unstructured":"Beck H, Jeske M, Thede K et al (2018) Discovery of molidustat (BAY 85-3934): a small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia. ChemMedChem 13:988\u20131003. https:\/\/doi.org\/10.1002\/cmdc.201700783","journal-title":"ChemMedChem"},{"key":"5361_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/acs.jproteome.1c00706","volume":"21","author":"S Loroch","year":"2022","unstructured":"Loroch S, Kopczynski D, Schneider AC et al (2022) Toward zero variance in proteomics sample preparation: positive-pressure FASP in 96-well format (PF96) enables highly reproducible, time- and cost-efficient analysis of sample cohorts. J Proteome Res 21:1181\u20131188. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00706","journal-title":"J Proteome Res"},{"key":"5361_CR34","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C et al (2022) The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res 50:D543\u2013D552. https:\/\/doi.org\/10.1093\/nar\/gkab1038","journal-title":"Nucleic Acids Res"},{"key":"5361_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci USA"},{"key":"5361_CR36","unstructured":"Doneanu CE, Chen W, Mazzeo JR (2011) UPLC\/MS monitoring of water-soluble vitamin Bs in cell culture media in minutes. In: www.waters.com. http:\/\/www.waters.com\/waters\/library.htm?lid=134636355. Accessed 29 Feb 2024"},{"key":"5361_CR37","doi-asserted-by":"publisher","first-page":"9457","DOI":"10.1021\/acs.analchem.8b02100","volume":"90","author":"JJ Hsiao","year":"2018","unstructured":"Hsiao JJ, Potter OG, Chu T-W, Yin H (2018) Improved LC\/MS methods for the analysis of metal-sensitive analytes using medronic acid as a mobile phase additive. Anal Chem 90:9457\u20139464. https:\/\/doi.org\/10.1021\/acs.analchem.8b02100","journal-title":"Anal Chem"},{"key":"5361_CR38","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1021\/acs.jproteome.9b00640","volume":"19","author":"KJ Adams","year":"2020","unstructured":"Adams KJ, Pratt B, Bose N et al (2020) Skyline for small molecules: a unifying software package for quantitative metabolomics. J Proteome Res 19:1447\u20131458. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00640","journal-title":"J Proteome Res"},{"key":"5361_CR39","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1152\/ajpendo.00457.2019","volume":"318","author":"A Chaudhry","year":"2020","unstructured":"Chaudhry A, Shi R, Luciani DS (2020) A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic \u03b2-cells. Am J Physiol Endocrinol Metab 318:E87\u2013E101. https:\/\/doi.org\/10.1152\/ajpendo.00457.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5361_CR40","doi-asserted-by":"publisher","first-page":"40670","DOI":"10.1038\/srep40670","volume":"7","author":"S Yin","year":"2017","unstructured":"Yin S, Kabashima T, Zhu Q et al (2017) Fluorescence assay of dihydroorotate dehydrogenase that may become a cancer biomarker. Sci Rep 7:40670. https:\/\/doi.org\/10.1038\/srep40670","journal-title":"Sci Rep"},{"key":"5361_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211","journal-title":"Nat Protoc"},{"key":"5361_CR42","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J et al (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50:W216\u2013W221. https:\/\/doi.org\/10.1093\/nar\/gkac194","journal-title":"Nucleic Acids Res"},{"key":"5361_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.587389","volume":"8","author":"S Gao","year":"2020","unstructured":"Gao S, Chen T, Li L et al (2020) Hypoxia-inducible ubiquitin specific peptidase 13 contributes to tumor growth and metastasis via enhancing the toll-like receptor 4\/myeloid differentiation primary response gene 88\/nuclear factor-\u03baB pathway in hepatocellular carcinoma. Front Cell Dev Biol 8:587389. https:\/\/doi.org\/10.3389\/fcell.2020.587389","journal-title":"Front Cell Dev Biol"},{"key":"5361_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/HP.S235967","volume":"7","author":"E-A Triantafyllou","year":"2019","unstructured":"Triantafyllou E-A, Mylonis I, Simos G, Paraskeva E (2019) Hypoxia induces pro-fibrotic and fibrosis marker genes in hepatocellular carcinoma cells independently of inflammatory stimulation and the NF-\u03ba\u0392 pathway. Hypoxia (Auckl) 7:87\u201391. https:\/\/doi.org\/10.2147\/HP.S235967","journal-title":"Hypoxia (Auckl)"},{"key":"5361_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111838","volume":"9","author":"I Flamme","year":"2014","unstructured":"Flamme I, Oehme F, Ellinghaus P et al (2014) Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85\u20133934 (Molidustat) stimulates erythropoietin production without hypertensive effects. PLoS ONE 9:e111838. https:\/\/doi.org\/10.1371\/journal.pone.0111838","journal-title":"PLoS ONE"},{"key":"5361_CR46","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.2337\/db21-0398","volume":"70","author":"MDL Sousa Fialho","year":"2021","unstructured":"Sousa Fialho MDL, Purnama U, Dennis KMJH et al (2021) Activation of HIF1\u03b1 rescues the hypoxic response and reverses metabolic dysfunction in the diabetic heart. Diabetes 70:2518\u20132531. https:\/\/doi.org\/10.2337\/db21-0398","journal-title":"Diabetes"},{"key":"5361_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.21037\/atm-21-4222","volume":"10","author":"Q Chu","year":"2022","unstructured":"Chu Q, Gu X, Zheng Q, Zhu H (2022) Regulatory mechanism of HIF-1\u03b1 and its role in liver diseases: a narrative review. Ann Transl Med 10:109. https:\/\/doi.org\/10.21037\/atm-21-4222","journal-title":"Ann Transl Med"},{"key":"5361_CR48","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1158\/0008-5472.CAN-11-3940","volume":"72","author":"MC Brahimi-Horn","year":"2012","unstructured":"Brahimi-Horn MC, Ben-Hail D, Ilie M et al (2012) Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance. Cancer Res 72:2140\u20132150. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3940","journal-title":"Cancer Res"},{"key":"5361_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41389-020-00251-5","volume":"9","author":"X-H Lin","year":"2020","unstructured":"Lin X-H, Qiu B-Q, Ma M et al (2020) Suppressing DRP1-mediated mitochondrial fission and mitophagy increases mitochondrial apoptosis of hepatocellular carcinoma cells in the setting of hypoxia. Oncogenesis 9:67. https:\/\/doi.org\/10.1038\/s41389-020-00251-5","journal-title":"Oncogenesis"},{"key":"5361_CR50","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1111\/febs.16164","volume":"289","author":"R Banerjee","year":"2022","unstructured":"Banerjee R, Purhonen J, Kallij\u00e4rvi J (2022) The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology. FEBS J 289:6936\u20136958. https:\/\/doi.org\/10.1111\/febs.16164","journal-title":"FEBS J"},{"key":"5361_CR51","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1021\/acs.jmedchem.5b00606","volume":"58","author":"M Lucas-Hourani","year":"2015","unstructured":"Lucas-Hourani M, Munier-Lehmann H, El Mazouni F et al (2015) Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines inhibitors of human dihydroorotate dehydrogenase (DHODH). J Med Chem 58:5579\u20135598. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00606","journal-title":"J Med Chem"},{"key":"5361_CR52","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","volume":"33","author":"S Christian","year":"2019","unstructured":"Christian S, Merz C, Evans L et al (2019) The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia 33:2403\u20132415. https:\/\/doi.org\/10.1038\/s41375-019-0461-5","journal-title":"Leukemia"},{"key":"5361_CR53","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/cancers14051259","volume":"14","author":"L Davis","year":"2022","unstructured":"Davis L, Recktenwald M, Hutt E et al (2022) Targeting HIF-2\u03b1 in the tumor microenvironment: redefining the role of HIF-2\u03b1 for solid cancer therapy. Cancers 14:1259. https:\/\/doi.org\/10.3390\/cancers14051259","journal-title":"Cancers"},{"key":"5361_CR54","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","volume":"116","author":"PP Kapitsinou","year":"2010","unstructured":"Kapitsinou PP, Liu Q, Unger TL et al (2010) Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116:3039\u20133048. https:\/\/doi.org\/10.1182\/blood-2010-02-270322","journal-title":"Blood"},{"key":"5361_CR55","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1101\/gad.268128.115","volume":"29","author":"JJ Kim","year":"2015","unstructured":"Kim JJ, Lee SB, Jang J et al (2015) WSB1 promotes tumor metastasis by inducing pVHL degradation. Genes Dev 29:2244\u20132257. https:\/\/doi.org\/10.1101\/gad.268128.115","journal-title":"Genes Dev"},{"key":"5361_CR56","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nsb936","volume":"10","author":"SJ Freedman","year":"2003","unstructured":"Freedman SJ, Sun Z-YJ, Kung AL et al (2003) Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol 10:504\u2013512. https:\/\/doi.org\/10.1038\/nsb936","journal-title":"Nat Struct Biol"},{"key":"5361_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/embor.2010.50","volume":"11","author":"T Landes","year":"2010","unstructured":"Landes T, Emorine LJ, Courilleau D et al (2010) The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep 11:459\u2013465. https:\/\/doi.org\/10.1038\/embor.2010.50","journal-title":"EMBO Rep"},{"key":"5361_CR58","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1080\/15548627.2020.1821548","volume":"17","author":"SC da Silva Rosa","year":"2021","unstructured":"da Silva Rosa SC, Martens MD, Field JT et al (2021) BNIP3L\/Nix-induced mitochondrial fission, mitophagy, and impaired myocyte glucose uptake are abrogated by PRKA\/PKA phosphorylation. Autophagy 17:2257\u20132272. https:\/\/doi.org\/10.1080\/15548627.2020.1821548","journal-title":"Autophagy"},{"key":"5361_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.594203","volume":"8","author":"Y Xie","year":"2020","unstructured":"Xie Y, Liu J, Kang R, Tang D (2020) Mitophagy receptors in tumor biology. Front Cell Dev Biol 8:594203. https:\/\/doi.org\/10.3389\/fcell.2020.594203","journal-title":"Front Cell Dev Biol"},{"key":"5361_CR60","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccr.2007.04.001","volume":"11","author":"H Zhang","year":"2007","unstructured":"Zhang H, Gao P, Fukuda R et al (2007) HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11:407\u2013420. https:\/\/doi.org\/10.1016\/j.ccr.2007.04.001","journal-title":"Cancer Cell"},{"key":"5361_CR61","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.yexmp.2017.05.004","volume":"102","author":"Z Li","year":"2017","unstructured":"Li Z, Qu L, Luo W et al (2017) Mig-6 is down-regulated in HCC and inhibits the proliferation of HCC cells via the P-ERK\/Cyclin D1 pathway. Exp Mol Pathol 102:492\u2013499. https:\/\/doi.org\/10.1016\/j.yexmp.2017.05.004","journal-title":"Exp Mol Pathol"},{"key":"5361_CR62","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.18632\/aging.204733","volume":"15","author":"H Zhou","year":"2023","unstructured":"Zhou H, Yang L, Lin X et al (2023) Integrated network findings reveal ubiquitin-specific protease 44 overexpression suppresses tumorigenicity of liver cancer. Aging (Albany NY) 15:4304\u20134318. https:\/\/doi.org\/10.18632\/aging.204733","journal-title":"Aging (Albany NY)"},{"key":"5361_CR63","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng SC, Quintin J, Cramer RA et al (2014) mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345:1250684. https:\/\/doi.org\/10.1126\/science.1250684","journal-title":"Science"},{"key":"5361_CR64","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41419-019-2155-3","volume":"10","author":"D Kung-Chun Chiu","year":"2019","unstructured":"Kung-Chun Chiu D, Pui-Wah Tse A, Law C-T et al (2019) Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF\/HEY1\/PINK1 pathway. Cell Death Dis 10:934. https:\/\/doi.org\/10.1038\/s41419-019-2155-3","journal-title":"Cell Death Dis"},{"key":"5361_CR65","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cmet.2011.10.008","volume":"14","author":"D Tello","year":"2011","unstructured":"Tello D, Balsa E, Acosta-Iborra B et al (2011) Induction of the mitochondrial NDUFA4L2 protein by HIF-1\u03b1 decreases oxygen consumption by inhibiting complex I activity. Cell Metab 14:768\u2013779. https:\/\/doi.org\/10.1016\/j.cmet.2011.10.008","journal-title":"Cell Metab"},{"key":"5361_CR66","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1158\/1078-0432.CCR-15-1987","volume":"22","author":"RK-H Lai","year":"2016","unstructured":"Lai RK-H, Xu IM-J, Chiu DK-C et al (2016) NDUFA4L2 fine-tunes oxidative stress in hepatocellular carcinoma. Clin Cancer Res 22:3105\u20133117. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1987","journal-title":"Clin Cancer Res"},{"key":"5361_CR67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2007.01.047","volume":"129","author":"R Fukuda","year":"2007","unstructured":"Fukuda R, Zhang H, Kim J et al (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129:111\u2013122. https:\/\/doi.org\/10.1016\/j.cell.2007.01.047","journal-title":"Cell"},{"key":"5361_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108340","volume":"33","author":"Y Yang","year":"2020","unstructured":"Yang Y, Zhang G, Guo F et al (2020) Mitochondrial UQCC3 modulates hypoxia adaptation by orchestrating OXPHOS and glycolysis in hepatocellular carcinoma. Cell Rep 33:108340. https:\/\/doi.org\/10.1016\/j.celrep.2020.108340","journal-title":"Cell Rep"},{"key":"5361_CR69","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1158\/0008-5472.CAN-16-0530","volume":"76","author":"D Samanta","year":"2016","unstructured":"Samanta D, Park Y, Andrabi SA et al (2016) PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis. Cancer Res 76:4430\u20134442. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0530","journal-title":"Cancer Res"},{"key":"5361_CR70","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbagrm.2019.06.004","volume":"1862","author":"S-H Choi","year":"2019","unstructured":"Choi S-H, Kim M-Y, Yoon Y-S et al (2019) Hypoxia-induced RelA\/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A. Biochim Biophys Acta Gene Regul Mech 1862:771\u2013785. https:\/\/doi.org\/10.1016\/j.bbagrm.2019.06.004","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"5361_CR71","doi-asserted-by":"publisher","first-page":"76816","DOI":"10.18632\/oncotarget.12713","volume":"7","author":"MA Applebaum","year":"2016","unstructured":"Applebaum MA, Jha AR, Kao C et al (2016) Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients. Oncotarget 7:76816\u201376826. https:\/\/doi.org\/10.18632\/oncotarget.12713","journal-title":"Oncotarget"},{"key":"5361_CR72","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1158\/0008-5472.CAN-15-0405","volume":"75","author":"MZ Noman","year":"2015","unstructured":"Noman MZ, Janji B, Hu S et al (2015) Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210. Cancer Res 75:3771\u20133787. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-0405","journal-title":"Cancer Res"},{"key":"5361_CR73","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, M\u00fcller C, Park S et al (2023) Arginine reprograms metabolism in liver cancer via RBM39. Cell 186:5068-5083.e23. https:\/\/doi.org\/10.1016\/j.cell.2023.09.011","journal-title":"Cell"},{"key":"5361_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.848214","volume":"10","author":"S Wang","year":"2022","unstructured":"Wang S, Tan J, Miao Y, Zhang Q (2022) Mitochondrial dynamics, mitophagy, and mitochondria-endoplasmic reticulum contact sites crosstalk under hypoxia. Front Cell Dev Biol 10:848214. https:\/\/doi.org\/10.3389\/fcell.2022.848214","journal-title":"Front Cell Dev Biol"},{"key":"5361_CR75","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cmet.2006.01.012","volume":"3","author":"I Papandreou","year":"2006","unstructured":"Papandreou I, Cairns RA, Fontana L et al (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187\u2013197. https:\/\/doi.org\/10.1016\/j.cmet.2006.01.012","journal-title":"Cell Metab"},{"key":"5361_CR76","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","volume":"3","author":"J Kim","year":"2006","unstructured":"Kim J, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177\u2013185. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.002","journal-title":"Cell Metab"},{"key":"5361_CR77","doi-asserted-by":"publisher","first-page":"28106","DOI":"10.1074\/jbc.M803508200","volume":"283","author":"C-W Lu","year":"2008","unstructured":"Lu C-W, Lin S-C, Chen K-F et al (2008) Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem 283:28106\u201328114. https:\/\/doi.org\/10.1074\/jbc.M803508200","journal-title":"J Biol Chem"},{"key":"5361_CR78","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","volume":"29","author":"DA Cappel","year":"2019","unstructured":"Cappel DA, Deja S, Duarte JAG et al (2019) Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab 29:1291-1305.e8. https:\/\/doi.org\/10.1016\/j.cmet.2019.03.014","journal-title":"Cell Metab"},{"key":"5361_CR79","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41419-018-0987-x","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li H, Chang H et al (2018) MTP18 overexpression contributes to tumor growth and metastasis and associates with poor survival in hepatocellular carcinoma. Cell Death Dis 9:956. https:\/\/doi.org\/10.1038\/s41419-018-0987-x","journal-title":"Cell Death Dis"},{"key":"5361_CR80","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1038\/s41467-022-31187-6","volume":"13","author":"S Li","year":"2022","unstructured":"Li S, Han S, Zhang Q et al (2022) FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion. Nat Commun 13:3486. https:\/\/doi.org\/10.1038\/s41467-022-31187-6","journal-title":"Nat Commun"},{"key":"5361_CR81","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1126\/science.abi7495","volume":"374","author":"JB Spinelli","year":"2021","unstructured":"Spinelli JB, Rosen PC, Sprenger H-G et al (2021) Fumarate is a terminal electron acceptor in the mammalian electron transport chain. Science 374:1227\u20131237. https:\/\/doi.org\/10.1126\/science.abi7495","journal-title":"Science"},{"key":"5361_CR82","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/0026-0495(80)90076-1","volume":"29","author":"OE Owen","year":"1980","unstructured":"Owen OE, Mozzoli MA, Boden G et al (1980) Substrate, hormone, and temperature responses in males and females to a common breakfast. Metabolism 29:511\u2013523. https:\/\/doi.org\/10.1016\/0026-0495(80)90076-1","journal-title":"Metabolism"},{"key":"5361_CR83","doi-asserted-by":"publisher","first-page":"7091718","DOI":"10.1155\/2020\/7091718","volume":"2020","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Guo S, Xie C, Fang J (2020) Uridine metabolism and its role in glucose, lipid, and amino acid homeostasis. Biomed Res Int 2020:7091718. https:\/\/doi.org\/10.1155\/2020\/7091718","journal-title":"Biomed Res Int"},{"key":"5361_CR84","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhl\u00e9n","year":"2017","unstructured":"Uhl\u00e9n M, Zhang C, Lee S et al (2017) A pathology atlas of the human cancer transcriptome. Science 357:eaan2507. https:\/\/doi.org\/10.1126\/science.aan2507","journal-title":"Science"},{"key":"5361_CR85","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yexcr.2014.11.018","volume":"331","author":"T Geis","year":"2015","unstructured":"Geis T, D\u00f6ring C, Popp R et al (2015) HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma. Exp Cell Res 331:46\u201357. https:\/\/doi.org\/10.1016\/j.yexcr.2014.11.018","journal-title":"Exp Cell Res"},{"key":"5361_CR86","doi-asserted-by":"publisher","first-page":"22880","DOI":"10.18632\/oncotarget.4412","volume":"6","author":"X-P Li","year":"2015","unstructured":"Li X-P, Yang X-Y, Biskup E et al (2015) Co-expression of CXCL8 and HIF-1\u03b1 is associated with metastasis and poor prognosis in hepatocellular carcinoma. Oncotarget 6:22880\u201322889. https:\/\/doi.org\/10.18632\/oncotarget.4412","journal-title":"Oncotarget"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05361-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:14:21Z","timestamp":1722334461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5361"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05361-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"320"}}